Accueil / Nouvelles et Évènements
Points saillants de la recherche
Solving blood supply shortage with glycomics
GlycoNet Investigators study the sugars on red blood cells to find ways to make universal donor blood
GlycoNet start-up listed as top 10 therapeutics start-ups and companies in Edmonton
48Hour Discovery shows exceptional innovation, growth, management, and societal impact, according to BestStartup.
GlycoNet Investigator develops new chemistry to facilitate drug development and manufacturing
The collaborative project is partnered with CQDM, Simon Fraser University, Amgen, Merck, and Servier.
More stories
- Tout
- Prix
- Communauté
- Profil du Réseau
- Communiqué de presse
- Points saillants de la recherche
Carbohydrate ‘cage’ allows precise drug delivery to inflammation site in the gastrointestinal tract
A GlycoCage technology developed by GlycoNet researchers aims to improve current treatments for inflammatory bowel disease
Pooling Canadian innovation efforts to make breakthrough discoveries
Scientific collaboration yields new hope for children affected by rare blood disorder
GlycoNet Investigator meets the Parliamentary Health Research Caucus to present glycomics research
Dr. Yves St-Pierre shared how glycomics could help develop a new-generation cancer immunotherapy.
GlycoNet announces 15 projects awarded as part of its Glycomics Training Program
Trainees will receive support and resources while advancing glycomics research in areas such as antimicrobials, drug discovery, immune response, cancer, and neurodegenerative diseases
GlycoNet Investigator received McGill’s Principal’s Prize for Public Engagement Through Media
From offering policy advice to sharing his expertise on COVID-19 with the media and public, Dr. Donald Sheppard is recognized a role model with his achievement in engaging with the broader community
GlycoNet and BridgeBio Pharma Inc. initiate collaboration to discover potential treatments for genetic diseases through glycomics research
Genetic disease research has benefitted substantially from the study of glycomics, which relates to the functions of glycans, or sugar, in biological systems
GlycoNet researchers discover how a plaque-fighting protein protects against Alzheimer’s
Research highlights potential pathway for new treatments for neurodegenerative diseases
GlycoNet Investigator featured in “100 Lives of Insulin” project
Dr. Mike Riddell has spent his career looking at ways to make diabetes easier and safer for those who are living with it. He talks about the why and how behind it.
Canadian Glycomics Network launches Call for Proposals for glycomics projects to address fundamental health challenges in Canada
The Network will commit $1.8 million in glycomics to support made-in-Canada health innovations and build a sustainable national bioeconomy
Réseau Canadien de la Glycomique
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
Tél.: 780-492-6204
Téléc.: 780-492-4147
© Réseau Canadien de la Glycomique (GlycoNet). Tous droits réservés.
French 
English